Skip to content

Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction

Dr Kimberly Scarsi presenting to CROI 2021.

Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years

Karan Bunjean/Shutterstock.com

Dolutegravir superior to standard-of-care treatment in children and adolescents

Dr Anna Turkova (left) presenting to CROI 2021.

Targeted screening improves TB diagnosis in people with HIV in South Africa

Dr Limakatso Lebina (bottom row) presenting to CROI 2021.

Social networks key to PrEP uptake in rural Kenya and Uganda

Dr Catherine Koss (bottom left) presenting to CROI 2021.

People with HIV and hepatitis B should have ongoing monitoring for liver cancer

Dr H. Nina Kim (centre right) presenting to CROI 2021.

mRNA vaccine protects monkeys against HIV-like virus

Slide from Dr Peng Zhang's presentation to CROI 2021.

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

Professor Raphael Landovitz presenting to CROI 2021.

Therapeutic vaccine shows potential for HIV control off treatment in early study

Dr Beatriz Mothe (bottom left) presenting to CROI 2021.